Publications by authors named "Michael Schwemmlein"
Page 1 of 1
Synopsis of recent research by authors named "Michael Schwemmlein"
- Michael Schwemmlein's research primarily focuses on the development of innovative antibody-based therapies and targeted delivery systems for cancer treatment, specifically targeting acute myeloid leukemia and various tumors through advanced immunotherapeutic strategies.
- Significant findings from his work include the creation of single-chain Fv triplebodies (sctbs) and bispecific antibodies that enhance immune effector functions against leukemic cells, demonstrating improved apoptosis induction in cultured cell lines.
- Additionally, Schwemmlein's studies highlight the potential of using siRNA and immunotoxins for targeted therapies, showcasing successful delivery mechanisms and substantial cytotoxic effects on tumor cells, ultimately paving the way for more effective cancer treatments.
